Harlan S. Robins
Chief Scientific Officer · Adaptive Biotechnologies Corp
- 2025
- Jul 23, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Harlan S. Robins files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chad M. Robins - $37.85M in ADPT purchases and sales in the last 12 months
- Julie Rubinstein - $16.25M in ADPT purchases and sales in the last 12 months
- Sharon Benzeno - $14.48M in ADPT purchases and sales in the last 12 months
- Francis Lo - $11.99M in ADPT purchases and sales in the last 12 months
- Kyle Piskel - $3.58M in ADPT purchases and sales in the last 12 months
- Peter M. Neupert - $3.14M in ADPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Harlan S. Robins?
Harlan S. Robins is a corporate insider, tracked as Chief Scientific Officer of Adaptive Biotechnologies Corp (ADPT). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Harlan S. Robins submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Harlan S. Robins been buying or selling stock?
Recorded transactions: 0 open-market purchases and 16 open-market sales ($29.48M) across all tracked filings.
